Oral contraceptives and lipids and lipoproteins

Part I-variations in mean levels by oral contraceptive type

Ronald T. Burkman, Howard A Zacur, Allyn W. Kimball, Peter Kwiterovich, William R. Bell

Research output: Contribution to journalArticle

Abstract

A randomized clinical trial of oral contraceptives evaluated 67 women on 50 ug ethinyl estradiol (EE) and 1.0 mg norethindrone (NE), 61 women on 35 ug EE and 1.0 mg NE, and 64 women on 35 ug EE and 0.5 mg NE. Fasting lipids and lipoproteins were measured at baseline, three, six and nine months. All groups showed an increase in plasma total cholesterol, triglycerides, low-density lipoprotein/apolipoprotein B and apolipoprotein A-1. The group taking the preparation with 0.5 mg of NE was the only one to result in an elevation of high-density lipoprotein cholesterol; the other two groups showed declines in the mean levels of this lipoprotein over the study time period. Mean changes in lipid/lipoprotein levels associated with oral contraceptive use appear to be at least partially related to the doses of the contraceptive steroids.

Original languageEnglish (US)
Pages (from-to)553-561
Number of pages9
JournalContraception
Volume40
Issue number5
DOIs
StatePublished - 1989

Fingerprint

Norethindrone
Oral Contraceptives
Lipoproteins
Ethinyl Estradiol
Lipids
Apolipoprotein A-I
Apolipoproteins B
Contraceptive Agents
LDL Cholesterol
HDL Cholesterol
Fasting
Randomized Controlled Trials
Steroids

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Oral contraceptives and lipids and lipoproteins : Part I-variations in mean levels by oral contraceptive type. / Burkman, Ronald T.; Zacur, Howard A; Kimball, Allyn W.; Kwiterovich, Peter; Bell, William R.

In: Contraception, Vol. 40, No. 5, 1989, p. 553-561.

Research output: Contribution to journalArticle

Burkman, Ronald T. ; Zacur, Howard A ; Kimball, Allyn W. ; Kwiterovich, Peter ; Bell, William R. / Oral contraceptives and lipids and lipoproteins : Part I-variations in mean levels by oral contraceptive type. In: Contraception. 1989 ; Vol. 40, No. 5. pp. 553-561.
@article{ad9337ae75d1478381e580ffeebd2c1a,
title = "Oral contraceptives and lipids and lipoproteins: Part I-variations in mean levels by oral contraceptive type",
abstract = "A randomized clinical trial of oral contraceptives evaluated 67 women on 50 ug ethinyl estradiol (EE) and 1.0 mg norethindrone (NE), 61 women on 35 ug EE and 1.0 mg NE, and 64 women on 35 ug EE and 0.5 mg NE. Fasting lipids and lipoproteins were measured at baseline, three, six and nine months. All groups showed an increase in plasma total cholesterol, triglycerides, low-density lipoprotein/apolipoprotein B and apolipoprotein A-1. The group taking the preparation with 0.5 mg of NE was the only one to result in an elevation of high-density lipoprotein cholesterol; the other two groups showed declines in the mean levels of this lipoprotein over the study time period. Mean changes in lipid/lipoprotein levels associated with oral contraceptive use appear to be at least partially related to the doses of the contraceptive steroids.",
author = "Burkman, {Ronald T.} and Zacur, {Howard A} and Kimball, {Allyn W.} and Peter Kwiterovich and Bell, {William R.}",
year = "1989",
doi = "10.1016/0010-7824(89)90127-3",
language = "English (US)",
volume = "40",
pages = "553--561",
journal = "Contraception",
issn = "0010-7824",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Oral contraceptives and lipids and lipoproteins

T2 - Part I-variations in mean levels by oral contraceptive type

AU - Burkman, Ronald T.

AU - Zacur, Howard A

AU - Kimball, Allyn W.

AU - Kwiterovich, Peter

AU - Bell, William R.

PY - 1989

Y1 - 1989

N2 - A randomized clinical trial of oral contraceptives evaluated 67 women on 50 ug ethinyl estradiol (EE) and 1.0 mg norethindrone (NE), 61 women on 35 ug EE and 1.0 mg NE, and 64 women on 35 ug EE and 0.5 mg NE. Fasting lipids and lipoproteins were measured at baseline, three, six and nine months. All groups showed an increase in plasma total cholesterol, triglycerides, low-density lipoprotein/apolipoprotein B and apolipoprotein A-1. The group taking the preparation with 0.5 mg of NE was the only one to result in an elevation of high-density lipoprotein cholesterol; the other two groups showed declines in the mean levels of this lipoprotein over the study time period. Mean changes in lipid/lipoprotein levels associated with oral contraceptive use appear to be at least partially related to the doses of the contraceptive steroids.

AB - A randomized clinical trial of oral contraceptives evaluated 67 women on 50 ug ethinyl estradiol (EE) and 1.0 mg norethindrone (NE), 61 women on 35 ug EE and 1.0 mg NE, and 64 women on 35 ug EE and 0.5 mg NE. Fasting lipids and lipoproteins were measured at baseline, three, six and nine months. All groups showed an increase in plasma total cholesterol, triglycerides, low-density lipoprotein/apolipoprotein B and apolipoprotein A-1. The group taking the preparation with 0.5 mg of NE was the only one to result in an elevation of high-density lipoprotein cholesterol; the other two groups showed declines in the mean levels of this lipoprotein over the study time period. Mean changes in lipid/lipoprotein levels associated with oral contraceptive use appear to be at least partially related to the doses of the contraceptive steroids.

UR - http://www.scopus.com/inward/record.url?scp=0024462480&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024462480&partnerID=8YFLogxK

U2 - 10.1016/0010-7824(89)90127-3

DO - 10.1016/0010-7824(89)90127-3

M3 - Article

VL - 40

SP - 553

EP - 561

JO - Contraception

JF - Contraception

SN - 0010-7824

IS - 5

ER -